Javascript verkar inte påslaget? - Vissa delar av Lunds universitets webbplats fungerar inte optimalt utan javascript, kontrollera din webbläsares inställningar.
Du är här

Integrating disease knowledge and technology to deliver protein targets and biomarkers into drug discovery projects

Publiceringsår: 2005
Språk: Engelska
Sidor: 345-351
Publikation/Tidskrift/Serie: Drug Discovery Today: Technologies
Volym: 2
Nummer: 4
Dokumenttyp: Artikel i tidskrift
Förlag: Elsevier


Biomarker discovery is dependent upon two disciplines: the field of clinical bioanalysis linked to disease aetiology and the application of high level technology platforms for identifying proteins/peptides in complex samples. However, diagnostic biomarker measurements require certain definitions of context that can only be achieved by combining protein science with clinical science. The evaluation of biomarkers requires careful attention to match (1) a specific biological question with (2) the appropriate clinical sample and (3) high resolution technology systems which link protein identities to clinical informatics.


  • Analytical Chemistry
  • Medical Engineering


  • ISSN: 1740-6749

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen